Skip to content

Clinical trials

Observational Leukemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Observational Country / region: United States Clear all

154 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20014
20025
20034
20047
20054
20069
20077
200815
20098
20105
20114
20122
20136
20146
20155
20166
20172
20185
20193
20204
20218
20224
20232
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed87
Recruiting24
Terminated16
Unknown status12
Active, not recruiting8
Withdrawn4
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)18
M.D. Anderson Cancer Center13
Alliance for Clinical Trials in Oncology11
Children's Oncology Group10
Memorial Sloan Kettering Cancer Center7
St. Jude Children's Research Hospital7
Fred Hutchinson Cancer Center5
Case Comprehensive Cancer Center4
Stanford University4
Wake Forest University Health Sciences4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia154
Lymphoma67
Leukemia, Myeloid, Acute39
Myelodysplastic Syndromes36
Precursor Cell Lymphoblastic Leukemia-Lymphoma35
Lymphoma, Non-Hodgkin33
Multiple Myeloma30
Hodgkin Disease26
Leukemia, Lymphocytic, Chronic, B-Cell24
Congenital Abnormalities22

Trials

Showing 1 to 25 of 154. Each trial links to its page on Pharma Observatory.

54 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.